Production of interleukin-1-receptor antagonist during experimental endotoxaemia

Lancet. 1991 Dec 7;338(8780):1423-4. doi: 10.1016/0140-6736(91)92725-h.

Abstract

Interleukin-1 (IL-1) has been implicated in the pathogenesis of sepsis. IL-1-receptor antagonist (IL-1ra) is a naturally occurring inhibitor of IL-1 activity that competes with IL-1 for occupancy of cell-surface receptors but possesses no agonist activity. We induced endotoxaemia in 9 healthy human volunteers by injection of Escherichia coli endotoxin, and measured plasma concentrations of IL-1 and IL-1ra by radioimmunoassay during the next 24 h. Peak plasma concentrations of IL-1ra were about a hundred-fold greater than those of IL-1 beta. No IL-1 or IL-1ra were detectable in the plasma of 4 volunteers injected with saline. Our results suggest that the predominant natural response to endotoxin in man is the production of antagonist rather than agonist.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Endotoxins / blood
  • Endotoxins / pharmacology*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1 / analysis
  • Interleukin-1 / antagonists & inhibitors*
  • Male
  • Middle Aged
  • Protein Biosynthesis*
  • Proteins / analysis
  • Receptors, Immunologic / antagonists & inhibitors*
  • Receptors, Interleukin-1
  • Sialoglycoproteins*
  • Time Factors

Substances

  • Endotoxins
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Proteins
  • Receptors, Immunologic
  • Receptors, Interleukin-1
  • Sialoglycoproteins
  • endotoxin, Escherichia coli